Language Select
Logótipo Varian

Notícias recentes

Janeiro 14, 2019
With nearly 1,300 Chinese radiation oncology professionals in attendance and an additional 8,000 users watching via a live webcast, Varian (NYSE: VAR) recently held its 2019 China Users Meeting in... Read more
Dezembro 24, 2018
Varian (NYSE: VAR) today announced it received notification from the United States Trade Representative (USTR) that its exclusion request for Halcyon™ radiotherapy systems for cancer treatments,... Read more
Dezembro 19, 2018
Varian (NYSE: VAR) today announced that Dow Wilson, chief executive officer, and Chris Toth, president of Oncology Systems, will present at the J.P. Morgan Healthcare Conference in San Francisco,... Read more

Publicações recentes do blogue

Dez 13, 2018 | Centerline
ARIA® for Medical Oncology was recently rolled out across Northern Ireland. As a result, every cancer patient in a province of nearly two million people now has a clinical record within the ARIA... Read more
Dez 07, 2018 | Centerline
The radiation oncology department at Loyola University Medical Center is using ARIA® Connect to bridge the gap between ARIA and the Epic® electronic health record used by the larger medical center.... Read more
Dez 06, 2018 | Centerline
83-year-old New Jersey Resident Among the First in the U.S. to Receive a Calypso-Guided Treatment for Cancer of the Lung... Read more

Receber notícias por e-mail
Assinar agora

Corporate Communications Contact

Mark Plungy
Director, Public Relations
650.424.5630
mark.plungy@varian.com

Investor Relations Contact

Mike Bruff
SVP, Investor Relations
650.424.5163
investors@varian.com

Monica Prokocki
Director, Investor Relations
650.424.5184
investors@varian.com